Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

400 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Optimal therapy of hepatitis C.
Di Bisceglie AM, Hoofnagle JH. Di Bisceglie AM, et al. Hepatology. 2002 Nov;36(5 Suppl 1):S121-7. doi: 10.1053/jhep.2002.36228. Hepatology. 2002. PMID: 12407585 Review.
Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status.
Di Bisceglie AM, Lyra AC, Schwartz M, Reddy RK, Martin P, Gores G, Lok AS, Hussain KB, Gish R, Van Thiel DH, Younossi Z, Tong M, Hassanein T, Balart L, Fleckenstein J, Flamm S, Blei A, Befeler AS; Liver Cancer Network. Di Bisceglie AM, et al. Am J Gastroenterol. 2003 Sep;98(9):2060-3. doi: 10.1111/j.1572-0241.2003.t01-1-07641.x. Am J Gastroenterol. 2003. PMID: 14499788
Roles of iron and HFE mutations on severity and response to therapy during retreatment of advanced chronic hepatitis C.
Bonkovsky HL, Naishadham D, Lambrecht RW, Chung RT, Hoefs JC, Nash SR, Rogers TE, Banner BF, Sterling RK, Donovan JA, Fontana RJ, Di Bisceglie AM, Ghany MG, Morishima C; HALT-C Trial Group. Bonkovsky HL, et al. Among authors: di bisceglie am. Gastroenterology. 2006 Nov;131(5):1440-51. doi: 10.1053/j.gastro.2006.08.036. Epub 2006 Aug 18. Gastroenterology. 2006. PMID: 17101320 Clinical Trial.
Impact of disease severity on outcome of antiviral therapy for chronic hepatitis C: Lessons from the HALT-C trial.
Everson GT, Hoefs JC, Seeff LB, Bonkovsky HL, Naishadham D, Shiffman ML, Kahn JA, Lok AS, Di Bisceglie AM, Lee WM, Dienstag JL, Ghany MG, Morishima C; HALT-C Trial Group. Everson GT, et al. Among authors: di bisceglie am. Hepatology. 2006 Dec;44(6):1675-84. doi: 10.1002/hep.21440. Hepatology. 2006. PMID: 17133499 Free article. Clinical Trial.
Health-related quality of life in patients with chronic hepatitis C and advanced fibrosis.
Bonkovsky HL, Snow KK, Malet PF, Back-Madruga C, Fontana RJ, Sterling RK, Kulig CC, Di Bisceglie AM, Morgan TR, Dienstag JL, Ghany MG, Gretch DR; HALT-C Trial Group. Bonkovsky HL, et al. Among authors: di bisceglie am. J Hepatol. 2007 Mar;46(3):420-31. doi: 10.1016/j.jhep.2006.10.009. Epub 2006 Nov 27. J Hepatol. 2007. PMID: 17196293 Free PMC article. Clinical Trial.
Impact of reducing peginterferon alfa-2a and ribavirin dose during retreatment in patients with chronic hepatitis C.
Shiffman ML, Ghany MG, Morgan TR, Wright EC, Everson GT, Lindsay KL, Lok AS, Bonkovsky HL, Di Bisceglie AM, Lee WM, Dienstag JL, Gretch DR. Shiffman ML, et al. Among authors: di bisceglie am. Gastroenterology. 2007 Jan;132(1):103-12. doi: 10.1053/j.gastro.2006.11.011. Epub 2006 Nov 11. Gastroenterology. 2007. PMID: 17241864 Clinical Trial.
400 results